Swedish Orphan Biovitrum Forecast, price target & analysts
Swedish Orphan Biovitrum Target price 2025 - Analyst rating & recommendation
Swedish Orphan Biovitrum Classifications & Recommendation:
Swedish Orphan Biovitrum Price Target
| Target Price | SEK353.42 |
| Price | SEK277.60 |
| Potential |
27.31%
register free of charge
|
| Number of Estimates | 12 |
|
12 Analysts have issued a price target Swedish Orphan Biovitrum 2026 .
The average Swedish Orphan Biovitrum target price is SEK353.42.
This is
27.31%
register free of charge
SEK393.00
41.57%
register free of charge
SEK285.00
2.67%
register free of charge
|
|
| A rating was issued by 14 analysts: 10 Analysts recommend Swedish Orphan Biovitrum to buy, 3 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Swedish Orphan Biovitrum stock has an average upside potential 2026 of
27.31%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion SEK | 26.03 | 27.98 |
| 17.64% | 7.51% | |
| EBITDA Margin | 36.65% | 37.20% |
| 3.61% | 1.51% | |
| Net Margin | 14.92% | 16.58% |
| 28.70% | 11.10% |
12 Analysts have issued a sales forecast Swedish Orphan Biovitrum 2025 . The average Swedish Orphan Biovitrum sales estimate is
This results in the following potential growth metrics:
11 Analysts have issued an Swedish Orphan Biovitrum EBITDA forecast 2025. The average Swedish Orphan Biovitrum EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
13 Swedish Orphan Biovitrum Analysts have issued a net profit forecast 2025. The average Swedish Orphan Biovitrum net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share SEK | 11.31 | 13.51 |
| 51.41% | 19.45% | |
| P/E | 20.55 | |
| EV/Sales | 3.97 |
13 Analysts have issued a Swedish Orphan Biovitrum forecast for earnings per share. The average Swedish Orphan Biovitrum EPS is
This results in the following potential growth metrics and future valuations:
Swedish Orphan Biovitrum...
Current Swedish Orphan Biovitrum Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| DNB MARKETS |
Locked
➜
Locked
|
Locked | Apr 02 2025 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Mar 31 2025 |
| HANDELSBANKEN CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | Mar 31 2025 |
| HSBC |
Locked
➜
Locked
|
Locked | Mar 23 2025 |
| PARETO SECURITIES AS |
Locked
➜
Locked
|
Locked | Feb 06 2025 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Feb 04 2025 |
| HANDELSBANKEN CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | Jan 26 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
DNB MARKETS:
Locked
➜
Locked
|
Apr 02 2025 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Mar 31 2025 |
|
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
➜
Locked
|
Mar 31 2025 |
|
Locked
HSBC:
Locked
➜
Locked
|
Mar 23 2025 |
|
Locked
PARETO SECURITIES AS:
Locked
➜
Locked
|
Feb 06 2025 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Feb 04 2025 |
|
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
➜
Locked
|
Jan 26 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
